fludarabine has been researched along with Neoplasms, Bone Marrow in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appelbaum, FR; Bennett, JM; Byrd, JC; Dewald, G; Flinn, IW; Grever, MR; Hussein, MA; Larson, RA; Lazarus, HM; Litzow, MR; Neuberg, D; Paietta, EM; Rowe, JM; Smith, MR; Tallman, MS | 1 |
| Argyrakos, T; Galani, V; Grigoriou, E; Harhalakis, N; Kanavaros, P; Kapsimali, V; Karmiris, T; Naum, C; Nikiforakis, E; Pantelidaki, C; Rontogianni, D; Tsantekidou, M | 1 |
| Bernardi, M; Bregni, M; Corradini, P; Deola, S; Fleischhauer, K; Guggiari, E; Lunghi, F; Mazzi, B; Monari, M; Peccatori, J; Pescarollo, A; Re, F; Scaramuzza, S; Servida, P; Setola, E | 1 |
1 review(s) available for fludarabine and Neoplasms, Bone Marrow
| Article | Year |
|---|---|
Blastic natural killer (NK)-cell lymphoma: report of an unusual CD4 negative case and review of the CD4 negative neoplasms with blastic features in the literature.
Topics: Adult; Blast Crisis; Bone Marrow Neoplasms; CD4 Antigens; Diagnosis, Differential; Fatal Outcome; Humans; Immunophenotyping; In Situ Hybridization; Killer Cells, Natural; Lymphoma, Non-Hodgkin; Male; Neoplasm Invasiveness; RNA, Viral; Skin Neoplasms; Vidarabine | 2004 |
1 trial(s) available for fludarabine and Neoplasms, Bone Marrow
| Article | Year |
|---|---|
Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Cohort Studies; Cyclophosphamide; Female; Follow-Up Studies; Humans; Incidence; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasms, Second Primary; Time Factors; United States; Vidarabine | 2011 |
1 other study(ies) available for fludarabine and Neoplasms, Bone Marrow
| Article | Year |
|---|---|
Bone marrow mammaglobin expression as a marker of graft-versus-tumor effect after reduced-intensity allografting for advanced breast cancer.
Topics: Adult; Biomarkers, Tumor; Bone Marrow; Bone Marrow Neoplasms; Bone Marrow Transplantation; Breast Neoplasms; Cyclophosphamide; Female; Gene Expression Regulation, Neoplastic; Graft Survival; Graft vs Tumor Effect; Humans; Mammaglobin A; Middle Aged; Myeloablative Agonists; Neoplasm Proteins; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; Thiotepa; Transplantation Conditioning; Transplantation, Homologous; Uteroglobin; Vidarabine | 2006 |